Trending Stock News

American Financial Group 401 Retirement & Savings Plan Stake in American Finl Group Ohio (AFG) Has Lowered as Valuation Rose; Bristol Myers Squibb Co (BMY) Stock Declined While Blb&B Advisors Has Upped Holding

American Financial Group Inc 401 Retirement & Savings Plan decreased its stake in American Finl Group Inc Ohio (AFG) by 1.84% based on its latest 2017Q3 regulatory filing with the SEC. American Financial Group Inc 401 Retirement & Savings Plan sold 52,876 shares as the company’s stock rose 5.81% with the market. The institutional investor held 2.83M shares of the finance company at the end of 2017Q3, valued at $292.53M, down from 2.88M at the end of the previous reported quarter. American Financial Group Inc 401 Retirement & Savings Plan who had been investing in American Finl Group Inc Ohio for a number of months, seems to be less bullish one the $9.65B market cap company. The stock increased 0.33% or $0.36 during the last trading session, reaching $109.36. About 348,526 shares traded or 2.47% up from the average. American Financial Group, Inc. (NYSE:AFG) has risen 40.27% since February 13, 2017 and is uptrending. It has outperformed by 23.57% the S&P500.

Blb&B Advisors Llc increased its stake in Bristol Myers Squibb Co (BMY) by 5.53% based on its latest 2017Q3 regulatory filing with the SEC. Blb&B Advisors Llc bought 4,944 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 94,336 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.01M, up from 89,392 at the end of the previous reported quarter. Blb&B Advisors Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $103.37 billion market cap company. The stock increased 0.73% or $0.46 during the last trading session, reaching $63.16. About 7.50 million shares traded or 12.50% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 13, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Blb&B Advisors Llc, which manages about $669.27 million and $649.25 million US Long portfolio, decreased its stake in Sysco Corp (NYSE:SYY) by 35,549 shares to 23,023 shares, valued at $1.24 million in 2017Q3, according to the filing. It also reduced its holding in Arconic Inc by 15,166 shares in the quarter, leaving it with 79,936 shares, and cut its stake in Mondelez Intl Inc (NASDAQ:MDLZ).

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Colony Group Lc, Massachusetts-based fund reported 6,658 shares. Iowa Bancorporation has invested 1.61% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Hartford Company invested in 362,189 shares. Blair William & Co Il has 740,645 shares for 0.35% of their portfolio. Yhb Investment owns 52,936 shares. Northwestern Mutual Wealth accumulated 0.05% or 104,701 shares. 581,758 were reported by Sei. Mcdaniel Terry holds 0.07% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 5,450 shares. 15,868 were reported by Lynch Associates In. Nippon Life stated it has 81,215 shares or 0.1% of all its holdings. Allsquare Wealth Mngmt Lc holds 0.11% or 2,100 shares in its portfolio. Inv invested in 1.23% or 17,025 shares. Qs Invsts Ltd Limited Liability Company reported 88,143 shares or 0.05% of all its holdings. Ghp Advisors holds 0.05% or 5,563 shares. Guyasuta Inv Advisors Incorporated has 36,109 shares for 0.28% of their portfolio.

Since September 6, 2017, it had 1 buy, and 2 sales for $646,385 activity. Another trade for 9,340 shares valued at $560,400 was made by Caldarella Joseph C on Wednesday, September 6. Lynch Thomas J. Jr. sold $335,172 worth of stock or 5,300 shares.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 71 analyst reports since July 28, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Hold” rating in Thursday, October 26 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Equal-Weight” rating by Barclays Capital on Friday, September 9. The rating was maintained by BMO Capital Markets on Tuesday, February 6 with “Underperform”. Piper Jaffray upgraded the stock to “Underweight” rating in Monday, August 24 report. Societe Generale initiated the stock with “Sell” rating in Wednesday, April 6 report. The firm has “Hold” rating by Deutsche Bank given on Monday, July 17. The company was maintained on Tuesday, February 6 by Leerink Swann. Cowen & Co maintained Bristol-Myers Squibb Company (NYSE:BMY) on Monday, July 10 with “Hold” rating. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, December 1. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Friday, September 22 by Piper Jaffray.

Since December 15, 2017, it had 0 buys, and 2 insider sales for $5.96 million activity. Shares for $5.81M were sold by Peraino Vito C.

Among 4 analysts covering American Financial Group (NYSE:AFG), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. American Financial Group had 7 analyst reports since January 19, 2016 according to SRatingsIntel. Bank of America maintained American Financial Group, Inc. (NYSE:AFG) on Thursday, February 1 with “Buy” rating. Macquarie Research downgraded American Financial Group, Inc. (NYSE:AFG) on Friday, December 2 to “Neutral” rating. The stock has “Buy” rating by Sandler O’Neill on Wednesday, January 10. The rating was maintained by Sandler O’Neill on Thursday, February 1 with “Buy”. The rating was upgraded by Sandler O’Neill on Friday, August 12 to “Buy”. The firm has “Hold” rating by Buckingham Research given on Monday, September 11.

Leave a Reply

Your email address will not be published. Required fields are marked *